Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3

• Hauptverfasser: Shichun Li (Verfasst von), Baokai Dou (Verfasst von), Shi Shu (Verfasst von), Luyao Wei (Verfasst von), Shiguo Zhu (Verfasst von), Zunji Ke (Verfasst von), Zhifei Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Natural killer (NK) cells, a key member of innate lymphocytes, are a promising immunotherapeutic target for ischemic stroke. Astragaloside IV (ASIV) is isolated from Astragalus mongholicus Bunge (Fabaceae), a herbal medicine possessing immunomodulatory ability. This study investigated the effect of...